Company: ICUI
Filing Date: 2025-04-03
Form Type: DEF 14A
Source: 0000883984-25-000010
Chunk: 55

Company: ICU MEDICAL INC/DE
Filing Date: 2025-04-03
Form: DEF 14A
Chunk 55
---
 | X           |     |                                   |     | X   |     | X,C |
| Elisha W. Finney     |     | X           |     |             |     | X,C                               |     | X   |     |     |
| David F. Hoffmeister |     | X           |     |             |     |                                   |     | X,C |     | X   |
| Donald M. Abbey      |     | X           |     |             |     | X                                 |     |     |     | X   |
| Laurie Hernandez     |     | X           |     |             |     | X                                 |     |     |     |     |
| Kolleen T. Kennedy   |     | X           |     |             |     | X                                 |     |     |     |     |

____________________________

NC Nominating Committee

AC Audit Committee

CC Compensation Committee

C Committee Chairperson

During 2024, the Board met six times, the Nominating Committee met two times, the Compensation Committee met five times and the Audit Committee met five times. All of our directors attended more than 75% of the total of all meetings of the Board and committees on which they served during 2024.

It is the policy of the Company to invite and encourage all members of the Board to attend each annual meeting of stockholders, which are generally held by remote communication. Five of our directors attended the 2024 Annual Meeting of Stockholders.

#### Board Leadership Structure
<div align='center'>40</div>

Vivek Jain is our CEO and Chairman of the Board. The Board believes that Mr. Jain is best situated to serve as Chairman of the Board based upon his significant leadership position with the Company and his extensive knowledge about the industry. In addition, the Board believes that Mr. Jain's combined roles as Chairman and CEO position him to effectively identify strategic priorities for the Company and to lead Board discussions on the execution of Company strategy. The Board believes that the combined role of Chairman and CEO helps promote the Company’s overall strategic development and facilitates the efficient flow of information between management and the Board.

The Board also believes that strong, independent Board leadership is a critical component of effective corporate governance, therefore, the Board established the position of Lead Independent Director and adopted a Lead Independent Director Charter. During 2024, David C. Greenberg was appointed to serve in the Lead Independent Director position.

The Lead Independent Director is elected annually by a majority of the independent directors upon receiving a